SpringWorks clears HSR and German antitrust hurdles for Merck KGaA merger

SpringWorks Therapeutics, Inc.

HSR waiting period expired June 13, 2025; Bundeskartellamt approved merger on May 20, 2025.
Transaction still subject to stockholder vote; special meeting to be held.
Merger expected to close in second half of 2025.
SpringWorks stockholders urged to read proxy statement filed with SEC.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.